Growth and growth hormone in children born small for gestational age.
At present, there are no uniform definitions for terms such as "small for gestational age" (SGA) and "catch-up growth" that can be used when evaluating children who are born small. Data suggest that growth hormone (GH) therapy can play a role in helping children born SGA achieve adequate height. For therapy to be successful, however, precise terminology must be defined and standardized, surveillance and identification of potential candidates must be performed, and treatment plans must be tailored to the unique needs of each patient. This manuscript focuses on each of these issues, and also identifies additional concerns that must be addressed as a consequence.
Rapaport
Robert
R
Division of Pediatric Endocrinology and Diabetes, Mount Sinai School of Medicine, One Gustave L. Levy Place, P.O. Box 1616, New York, NY 10029, USA. Robert.Rapaport@mountsinai.org
D006130:Growth Disorders / Q000188:drug therapy*; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age
D019382:Human Growth Hormone